Microtubule-disrupting agents can independently affect the prereplicative period and the entry into S phase stimulated by prostaglandin F2 alpha and fibroblastic growth factor.
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D003703:Demecolcine / Q000494:pharmacology; D015237:Dinoprost; D005346:Fibroblast Growth Factors; D007399:Interphase / Q000187:drug effects*; D051379:Mice; D008870:Microtubules / Q000187:drug effects*; D015739:Nocodazole; D010455:Peptides / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology*; D013997:Time Factors
D001562:Benzimidazoles; D010455:Peptides; D011460:Prostaglandins F; D005346:Fibroblast Growth Factors; D015237:Dinoprost; D015739:Nocodazole; D003078:Colchicine; D003703:Demecolcine